drugset / Trial / NCT00145275

To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women

NCT00145275

Phase 3 Completed 455 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

Zoledronic acid is a medicine being studied in people with low bone mass. Side effects such as headache, fever, muscle aches, and pains, may occur following the infusion. This study will investigate the use of over-the-counter medicines to improve these symptoms.

Timeline

Start
2004-12
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Background Zoledronic acid Other / unclassified

Indications

No indication recorded.